AI Science Tracker
EN

Mobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning

Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02139, United States · 23 Nov 2020 · medicine

Discovery

Mobile Health (mHealth) Viral Diagnostics Enabled with Adaptive Adversarial Learning

Source check: Source checked. Not independent scientific confirmation.

Finding: Adaptive adversarial image classifiers plus StyleGAN augmentation supported phone-based detection across five virus targets in 179 patient samples; the SARS-CoV-2 test panel had 62 nasal swabs and reported 100% sensitivity and specificity, with confidence intervals and a single study setting limiting interpretation.

Technology: Conditional adversarial neural networks adapt image classifiers across virus domains; StyleGAN produces synthetic images for the unlabeled target library.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Conditional adversarial neural networks adapt image classifiers across virus domains; StyleGAN produces synthetic images for the unlabeled target library.
Test and result
Results report 179 patient samples across five targets; SARS-CoV-2 panel n=62 reports 100% sensitivity/specificity and corresponding confidence intervals.
Limitation / still unknown
Independent test set uses patient samples and compares SARS-CoV-2 panel with qRT-PCR; evidence remains one study panel, not external deployment.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8299938/ · https://doi.org/10.1021/acsnano.0c06807 · https://pubmed.ncbi.nlm.nih.gov/33226787/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.